A real-world study of ART in France (REOLA) comparing a biosimilar rFSH against the originator according to rFSH starting dose

Paul Barrière,Samir Hamamah, Elisangela Arbo,Catherine Avril, Bruno Salle,Jean-Luc Pouly,Julian Jenkins

Journal of Gynecology Obstetrics and Human Reproduction（2023）

引用 1|浏览2

暂无评分

摘要

The REOLA study demonstrates that the cLBR with Bemfola® is very similar to Gonal-f® across all patient subpopulations. The cLBR is inversely related to the rFSH starting dose irrespective of the drug used, and the REOLA study provides reassurance of the clinical effectiveness of a biosimilar rFSH used in a real world setting.

查看译文

关键词

IVF/ICSI,Real world study,Biosimilar Follitropin,Bemfola,rFSH starting dose

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要